Detalles de la búsqueda
1.
Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy.
Hepatol Res
; 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38323994
2.
Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohort.
J Viral Hepat
; 30(5): 374-385, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36583600
3.
Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment.
J Viral Hepat
; 29(1): 52-59, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34695288
4.
A genome-wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites.
Liver Int
; 41(12): 2944-2953, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34309184
5.
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.
Ann Hepatol
; 19(4): 367-372, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32444247
6.
Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.
J Gastroenterol Hepatol
; 34(5): 937-946, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30160782
7.
Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy.
J Gastroenterol Hepatol
; 32(8): 1495-1502, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28109022
8.
Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination.
Ann Hepatol
; 16(5): 734-741, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28809743
9.
Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed.
Int J Mol Sci
; 18(5)2017 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28467359
10.
Cytoglobin deficiency promotes liver cancer development from hepatosteatosis through activation of the oxidative stress pathway.
Am J Pathol
; 185(4): 1045-60, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25665792
11.
Randomized trial of combined triple therapy comprising two types of peginterferon with simeprevir in patients with hepatitis C virus genotype 1b.
Hepatol Res
; 46(13): 1311-1320, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26932745
12.
Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver.
Lab Invest
; 94(2): 192-207, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24296877
13.
Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
Hepatology
; 57(1): 362-72, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22936459
14.
A case of hepatocellular carcinoma with "pseudoprogression" followed by complete response to atezolizumab plus bevacizumab.
Clin J Gastroenterol
; 16(3): 392-396, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36739366
15.
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis.
J Gastroenterol
; 58(4): 394-404, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729172
16.
Severity of Liver Fibrosis Is Associated with the Japanese Diet Pattern and Skeletal Muscle Mass in Patients with Nonalcoholic Fatty Liver Disease.
Nutrients
; 15(5)2023 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36904174
17.
Promotion of liver and lung tumorigenesis in DEN-treated cytoglobin-deficient mice.
Am J Pathol
; 179(2): 1050-60, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21684245
18.
Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment.
Sci Rep
; 12(1): 105, 2022 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34996935
19.
Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma.
JGH Open
; 6(11): 754-762, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36406645
20.
Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21.
FEBS Open Bio
; 12(12): 2122-2135, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36114826